Giulio (Filippo, Giacomo) Tarro

Editorial Board Member

President of the Foundation de Baumont Bonelli for cancer research Chairman of the Committee on Biotechnologies and VirusSphere, WABT - UNESCO, Paris

Contact Giulio (Filippo, Giacomo) Tarro

Department / University Information

President of the Foundation de Baumont Bonelli for cancer research Chairman of the Committee on Biotechnologies and VirusSphere, WABT - UNESCO

Biography

Dr. Giulio Tarro graduated from Medicine School, Naples University (1962). Currentely Dr.Giulio Tarro is President of the Foundation de Beaumont Bonelli fo cancer research, Chairman of the Committee on Biotechnologies and VirusSphere, WABT - UNESCO, Paris. Research Associate Division of Virology and Cancer Research, Children’s Hospital (1965-1968), Assistant Professor of Research Pediatrics, College Medicine (1968-1969), Cincinnati University, Ohio. Oncological Virology Professor, Naples University (1972-1985). Chief Division Virology (1973-2003), Head Department Diagnostic Laboratories, (2003-2006). D. Cotugno Hospital for Infectious Diseases, Naples; Emeritus, 2006 -. Since 2007 Chairman Committee of Biotechnologies and VirusSphere, World Academy Biomedical Technologies, UNESCO, Adjunct Professor Department Biology, Temple University, College of Science and Technology, Philadelphia, recipient of the Sbarro Health Research Organization lifetime achievement award (2010). His researches have been concerned with the characterization of specific virus-induced tumour antigens, which were the "finger-prints" left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

Research Interest

His basic researches have been concerned with antigens induced early during the replication cycle of human herpesviruses. Another study has involved the identification, isolation and characterization of specific virus-induced tumour antigens, which were the “finger-prints” left behind in human cancer. Achievements include patents in field; discovery of Respiratory Syncytial Virus in infant deaths in Naples and of tumor liberated protein as a tumor associated antigen, 55 kilodalton protein overexpressed in lung tumors and other epithelial adenocarcinomas.

Related Publications

Explore SciTechnol

Relavant Topics